Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Sensome
Newly Published Study Shows Sensome Clot-Sensing Guidewire Accurately Reveals True Clot Make-Up in Fully Occluded Brain Vessels for First Time
May 04, 2026
From
Sensome
Via
Business Wire
Sensome Announces Successful Proof‑of‑Concept Adding Its Biological Intelligence to Robotic Thrombectomy
March 17, 2026
From
Sensome
Via
Business Wire
New Study Shows That Innovative Methodology Powered by Sensome Technology Successfully Monitors Cancer Progression
July 17, 2025
From
Sensome
Via
Business Wire
Sensome Announces Enrollment Completion in First-in-Human Study of In Situ Tumor Detection System for Lung Cancer
May 27, 2025
From
Sensome
Via
Business Wire
Sensome Announces Data From Two New Studies Showing Clot-Sensing Guidewire Successfully Identifies Fresh Clot to Support Decision-Making in Peripheral Artery Disease Treatment
December 13, 2024
From
Sensome
Via
Business Wire
Sensome Announces First Patients Enrolled in First-in-Human Study Evaluating Feasibility of Real-Time, In Situ Tumor Confirmation System for Lung Cancer
September 10, 2024
From
Sensome
Via
Business Wire
Sensome Signs Exclusive Commercial Distribution Agreement for Clot-Sensing Guidewire in Japan With Cosmotec
July 10, 2024
From
Sensome
Via
Business Wire
First-in-Human Data for Sensome Clot-Sensing Guidewire Used in Ischemic Stroke Treatment Demonstrate Ability to Automate Clot Characterization With No Safety Issues
June 05, 2024
From
Sensome
Via
Business Wire
Sensome Announces Initiation of Clinical Trial Assessing Its Tissue Microsensor Technology in Peripheral Artery Disease
February 12, 2024
From
Sensome
Via
Business Wire
Sensome and Asahi Intecc Forge Partnership to Develop Next-Generation Smart Guidewire and Transform Stroke Treatment
June 21, 2023
From
SENSOME
Via
Business Wire
Sensome Begins Human Trial for Its AI-Powered Stroke Guidewire
September 13, 2021
From
Sensome
Via
Business Wire
Sensome Receives FDA “Breakthrough Device Designation” for its AI-powered Stroke Guidewire
June 21, 2021
From
Sensome
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.